🔎 Trials Near Me

Početna › Rak gastrointestinalnog trakta › Texas

Kliničke studije za Rak gastrointestinalnog trakta u državi Texas

26 studija za Rak gastrointestinalnog trakta traži sudionike na lokacijama u državi Texas.

Gradovi u državi Texas

Službeni tekst studije (engleski)

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Texas Oncology - West Texas, Abilene
  • Texas Oncology - West Texas, Amarillo
  • Texas Oncology - Gulf Coast, Beaumont
  • i još 27
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07222800

DESTINY-PANTUMOUR04

  • Research Site, Dallas
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07124000

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

  • GSK Investigational Site, Dallas
  • GSK Investigational Site, Houston
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07218926

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • MD Anderson, Houston
  • NEXT Dallas, Irving
  • NEXT Oncology San Antonio, San Antonio
  • i još 1
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • Baylor College of Medicine, Houston
  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology Dallas, Irving
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06445062

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

  • START San Antonio, San Antonio
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07539311

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • START San Antonio, San Antonio
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 27. kol 2026. · NCT06582017

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • The University of Texas, MD Anderson Cancer Center, Houston
  • UT Health Mays Cancer Center, San Antonio
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

  • GSK Investigational Site, Houston
  • GSK Investigational Site, San Antonio
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 3. kol 2026. · NCT06885034

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

  • M D Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 21. srp 2026. · NCT04629677

Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center

  • MD Anderson Cancer Center, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 14. srp 2026. · NCT06420206

A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

  • NEXT Dallas, Dallas
  • MD Anderson Cancer Center, Houston
  • NEXT Houston, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT07337525

Telephone Support in Advanced Gastrointestinal Cancer

  • MD Anderson Cancer Center, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 6. srp 2026. · NCT06532877

Improving Comprehensive Care of Cancer Patients

  • Baylor College of Medicine, Houston
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 30. lip 2026. · NCT05323409

BOLSTER: Learning New Skills to Thrive

  • The University of Texas MD Anderson Cancer Center, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 18. lip 2026. · NCT06936878

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

  • M D Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT00991094

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

  • Clemments University Hospital, Dallas
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 5. lip 2026. · NCT07039526

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Sarah Cannon Research Institute at Mary Crowley, Dallas
  • University of Texas, MD Anderson Cancer Center, Houston
  • START, San Antonio
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. lip 2026. · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • University of Texas at Austin, Austin
  • Mary Crowley Cancer Research, Dallas
  • The University of Texas MD Anderson Cancer Center, Houston
  • i još 1
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 15. svi 2026. · NCT05379985

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. tra 2026. · NCT07020221

Molecular Epidemiology of Biliary Tree Cancers

  • M D Anderson Cancer Center, Houston
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 17. tra 2026. · NCT05179486

Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection

  • Baylor College of Medicine, Houston
  • Baylor St. Lukes Medical Center (BSLMC), Houston
U tijeku regrutacija
Od 22 godina i više · Oba spola · Ažurirano 24. ožu 2026. · NCT06134687

Traction vs. No Traction in Colonic ESD

  • Baylor College of Medicine, Houston
  • Baylor St. Lukes Medical Center (BSLMC), Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 24. ožu 2026. · NCT06159634

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

  • UT Southwestern, Dallas
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 15. kol 2025. · NCT05406167

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.